Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Buchanan

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Biotechnology and Bioengineering|April 27, 2011
Coping with complexity: machine learning optimization of cell-free protein synthesisFilippo Caschera, Mark A Bedau, Andrew Buchanan, et al.
European Journal of Dermatology : EJD|July 22, 2022
Improvements in itch and sleep following treatment with baricitinib in combination with topical corticosteroids are associated with better quality of life and productivity in adult patients with moderate-to-severe atopic dermatitis: a post hoc analysis from BREEZE-AD7Koji Masuda, Amy M Delozier, Jill Kolodsick, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable regionKalliopi Skamaki, Stephane Emond, Matthieu Chodorge, et al.
Plos Computational Biology|March 5, 2024
LAP: Liability Antibody Profiler by sequence & structural mapping of natural and therapeutic antibodiesTadeusz Satława, Mateusz Tarkowski, Sonia Wróbel, et al.
The Journal of Headache and Pain|February 26, 2020
Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR studyRichard B Lipton, Louise Lombard, Dustin D Ruff, et al.
Nature Chemistry|May 16, 2024
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potencyAnna M Puszkarska, Bruck Taddese, Jefferson Revell, et al.
Dermatology and Therapy|April 16, 2026
How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based ApproachBrett King, Maryanne Senna, Manabu Ohyama, et al.
Open Forum Infectious Diseases|July 25, 2020
Changing the Use of HIV Pre-exposure Prophylaxis Among Men Who Have Sex With Men During the COVID-19 Pandemic in Melbourne, AustraliaEric P F Chow, Jane S Hocking, Jason J Ong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2021
Clinical Presentation of Incident Syphilis Among Men Who Have Sex with Men Taking HIV Pre-Exposure Prophylaxis in Melbourne, AustraliaJoanne Peel, Eric P F Chow, Ian Denham, et al.
Toxicology and Applied Pharmacology|July 17, 2018
Monoclonal antibody targeting of fibroblast growth factor receptor 1c causes cardiac valvulopathy in ratsNicholas Buss, Jean-Martin Lapointe, Lolke de Haan, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Biotechnology and Bioengineering|April 27, 2011
Coping with complexity: machine learning optimization of cell-free protein synthesisFilippo Caschera, Mark A Bedau, Andrew Buchanan, et al.
European Journal of Dermatology : EJD|July 22, 2022
Improvements in itch and sleep following treatment with baricitinib in combination with topical corticosteroids are associated with better quality of life and productivity in adult patients with moderate-to-severe atopic dermatitis: a post hoc analysis from BREEZE-AD7Koji Masuda, Amy M Delozier, Jill Kolodsick, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable regionKalliopi Skamaki, Stephane Emond, Matthieu Chodorge, et al.
Plos Computational Biology|March 5, 2024
LAP: Liability Antibody Profiler by sequence & structural mapping of natural and therapeutic antibodiesTadeusz Satława, Mateusz Tarkowski, Sonia Wróbel, et al.
The Journal of Headache and Pain|February 26, 2020
Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR studyRichard B Lipton, Louise Lombard, Dustin D Ruff, et al.
Nature Chemistry|May 16, 2024
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potencyAnna M Puszkarska, Bruck Taddese, Jefferson Revell, et al.
Dermatology and Therapy|April 16, 2026
How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based ApproachBrett King, Maryanne Senna, Manabu Ohyama, et al.
Open Forum Infectious Diseases|July 25, 2020
Changing the Use of HIV Pre-exposure Prophylaxis Among Men Who Have Sex With Men During the COVID-19 Pandemic in Melbourne, AustraliaEric P F Chow, Jane S Hocking, Jason J Ong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2021
Clinical Presentation of Incident Syphilis Among Men Who Have Sex with Men Taking HIV Pre-Exposure Prophylaxis in Melbourne, AustraliaJoanne Peel, Eric P F Chow, Ian Denham, et al.
Toxicology and Applied Pharmacology|July 17, 2018
Monoclonal antibody targeting of fibroblast growth factor receptor 1c causes cardiac valvulopathy in ratsNicholas Buss, Jean-Martin Lapointe, Lolke de Haan, et al.
Pageof 7